Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT05933265 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 175 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Lantern Pharma Inc. |
| Last Updated on CT.gov | March 6, 2025 (Mar 6, 2025) |
As of March 2, 2026: Clinical trial NCT05933265 is currently recruiting participants. This clinical trial study for advanced solid tumors is actively seeking new participants at 9 locations across the United States. The study is sponsored by Lantern Pharma Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05933265 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05933265 was last updated Mar 6, 2025 (March 6, 2025). HelloStudys verifies this status automatically.